glp-1 receptor agonists benefits Glucagon-like peptide 1 agonists: cardiovascular and mechanisms of action The Benefits of GLP-1 Therapy:

Numerous gastrointestinal conditions, such as irritable bowel syndrome, inflammatory bowel disease, and small intestinal bacterial overgrowth, have been associated with dysbiosis (an imbalance or disruption in the composition and diversity of the gut microbiome) [111]

Insulin Glargine in Combination with Metformin and Glimepiride in T2D Patients)94), 0.75- and 1.5-mg doses of once-weekly dulaglutide were compared with a 1.5-mg dose of insulin glargine, titrated to target a fasting blood glucose level around 100 mg/dL, based on metformin treatment

doi: 10.3233/JAD-2012-129028 41 CalsolaroVEdisonP

suggesting that above a certain threshold, the i.v

B., Madsbad, S

Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial